Your account has been temporarily locked due to incorrect sign in attempts and will be automatically unlocked in
For immediate assistance, contact Customer Service:
800-638-3030 (within USA), 301-223-2300 (international)
Lippincott Journals Subscribers, use your username or email along with your password to log in.
Registered users can save articles, searches, and manage email alerts.
All registration fields are required.
Flash Player 9.0.0 is required for the Video Gallery.
Get Adobe Flash Player.
Colleague's E-mail is Invalid
Your message has been successfully sent to your colleague.
Ziad Khoueir, MD, MSEd
September 2020, Volume 29, Issue 9;
Ahmed Versus Baerveldt Glaucoma Drainage Device in Uveitic Glaucoma: A Retrospective Comparative Study, Reza Razeghinejad, MD
Agreement Between 10-2 and 24-2C Visual Field Test Protocols for Detecting Glaucomatous Central Visual Field Defects, Tutul Chakravarti, MD
News Theme 2 by Audionautix is licensed under a Creative Commons Attribution license (https://creativecommons.org/licenses/by/4.0/) Artist: http://audionautix.com
Pooled Efficacy and Safety Profile of Netarsudil Ophthalmic Solution 0.02% in Patients With Open-angle Glaucoma or Ocular Hypertension, Inder P. Singh, MD
Every month the WGA associate advisory board selects the paper of the month. Our guest for the fourth episode is Eugene Shildkrot from the University of Virginia, USA. His paper reports the effect of multiple Anti-VEGF injections on glaucoma progression in susceptible eyes.
(News Theme 2 by Audionautix is licensed under a Creative Commons Attribution license (https://creativecommons.org/licenses/by/4.0/) Artist: http://audionautix.com)